Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isavuconazonium Sulfate for Injection in Chinese Patients With Invasive Mold Infections
CTR20222788Phase 4Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of isavuconazole in invasive aspergillosis (IA), mucormycosis, invasive mycoses, sponsored by Basilea Pharmaceutica. Started Nov 2022; status: completed.
02
Drugs
isavuconazole
03
Conditions
invasive aspergillosis (IA)mucormycosisinvasive mycoses
Beyond the preview
Go deeper on CTR20222788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222788.